Regencell Bioscience HoldingsRGC 
$5.00-6.19%24h
-6.19%24h
Global rank4128
Market cap$65.06M
Change 7d-11.97%
YTD Performance-52.38%
SP500 benchmarkUnderperform
P/E-11.11
P/S0
Revenue$0
Earnings-$6.06M
Dividend yield-
Main Sector
Healthcare
Category
Regencell Bioscience Holdings (RGC) Total Liabilities
RGC Total Liabilities in 2022: $632.32K
According to Regencell Bioscience Holdings latest financial reports the total liabilities of RGC is $632.32K, an decrease of -32.59% to 2022. At the end of 2022 company had $938.03K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Regencell Bioscience Holdings is responsible for during its operational activities.
Regencell Bioscience Holdings (RGC) Total Liabilities History from 2023 to 2022
-
Value:-
RGC Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $632.32K | -32.59% |
| 2022 | $938.03K | -78.38% |
| 2021 | $4.34M | 37.06% |
| 2020 | $3.16M | 52.03% |
| 2019 | $2.08M | - |
View the Top Total Liabilies Stocks
